Grown Rogue International (GRUSF) EBT Margin (2018 - 2026)
Grown Rogue International (GRUSF) recorded quarterly EBT Margin of 18.53% in Q1 2026, down 542767690.88% quarter-over-quarter from 0.0% in Q4 2025, and down 3775.0% on a YoY basis from 0.5% in Q1 2025.
Grown Rogue International (GRUSF) EBT Margin (2018 - 2026) Analysis & Trends
Grown Rogue International's EBT Margin history runs 9 years deep, the most recent figure standing at 18.53% for Q1 2026.
- In Q1 2026, EBT Margin fell 3775.0% year-over-year to 18.53%; the TTM figure through Mar 2026 stood at 0.0% (down 3161.0% YoY), while the FY2025 annual figure was 16.49%, up 1377.0% from the prior year.
- EBT Margin was 18.53% for Q1 2026 at Grown Rogue International, down from 0.0% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 44.88% in Q4 2024 to a low of 18.53% in Q1 2026.
- Historically, EBT Margin has averaged 10.65% across 5 years, with a median of 15.34% in 2023.
- The sharpest annual moves came in 2022 and 2025: EBT Margin surged 10920 bps in 2022, then tumbled 4488 bps in 2025.
- A 5-year view of EBT Margin shows it stood at 16.11% in 2022, then soared by 80 bps to 29.03% in 2023, then soared by 55 bps to 44.88% in 2024, then sank by 100 bps to 0.0% in 2025, then sank by 542767691 bps to 18.53% in 2026.
- The last three EBT Margin figures came in at 18.53% (Q1 2026), 0.0% (Q4 2025), and 31.88% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 10.97% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 33.51% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 40.73% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 25.87% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 30.30% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.35% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -156.77% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -16.70% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 41.45% |
| 10 | Grown Rogue International | - | - | 3.96 Mn | -18.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.53% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 31.88% |
| Jun 30, 2025 | -15.70% |
| Mar 31, 2025 | 19.22% |
| Dec 31, 2024 | 44.88% |
| Sep 30, 2024 | -5.84% |
| Jun 30, 2024 | 7.32% |
| Mar 31, 2024 | 16.77% |
| Dec 31, 2023 | 29.03% |
| Oct 31, 2023 | -5.09% |
| Jul 31, 2023 | 7.88% |
| Apr 30, 2023 | 15.34% |
| Jan 31, 2023 | 16.47% |
| Jan 31, 2022 | 16.11% |
| Oct 31, 2021 | 43.06% |
| Jul 31, 2021 | 25.23% |
| Apr 30, 2021 | -38.13% |
| Jan 31, 2021 | -93.09% |
| Jul 31, 2020 | -90.61% |